Moving Glycosylation Control Upstream
August 6, 2026
Samsung Biologics’ Sojeong Lee discusses why biologics developers are paying closer attention to glycosylation earlier in development.
7 min read
False
Advertisement
Interviews
What Did ASCO 2026 Reveal About the Future of Oncology?
By James Strachan
August 6, 2026
Six drug development leaders discuss smarter immunotherapy combinations, the enduring potential of small molecules, emerging modalities, and how cancer treatment could evolve over the next two decades
8 min read
How China Is Rewriting the Rules Global Drug Development
By James Strachan
August 5, 2026
In part two of our conversation, Lingshi Tan explores how China’s integrated biopharma ecosystem is reshaping assumptions about speed, cost, innovation, and cross-border clinical development
14 min read
Single-Cell Analysis Reveals Hidden CAR T Manufacturing Risks
July 23, 2026
Mission Bio’s Mike Molnar explains how single-cell multiomics could improve vector copy number analysis, product characterization, and safety assessment in CAR T development
5 min read
Why Drug Development Still Lacks Integration
July 21, 2026
John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines
4 min read
The Rise of China: From Science Cities to Global Ambition
By James Strachan, Kathryn Wighton
July 15, 2026
Daphne Smyth of Veristat on the rise of Chinese biopharma, regulatory realities, and what comes next
8 min read
Surviving CGT's Funding Winter
By Alun Evans, James Strachan
July 15, 2026
In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market
10 min read
Rewriting the Neuroscience Playbook
By James Strachan
June 23, 2026
Merz Therapeutics is exploring botulinum toxin in chronic pain – a test case for unconventional thinking in neuroscience drug development
4 min read
The Scalability Challenge in MSC Therapies
June 12, 2026
John Yoshi Shyu on why mesenchymal stem cell programs stall – and how early manufacturing decisions can determine clinical and commercial success
4 min read
Building the Cell Therapy Ecosystem
June 8, 2026
Antoinette Gawin discusses leadership, innovation in blood and cell therapy, and the global systems shaping access to advanced medicine
10 min read
